|

Reporting, Evaluating, Preventing and Treating the Cardiotoxicity Induced by Anticancer Drugs During a Specific Cardio-oncology Consult and Follow up in Routine Care

RECRUITINGSponsored by Groupe Hospitalier Pitie-Salpetriere
Actively Recruiting
SponsorGroupe Hospitalier Pitie-Salpetriere
Started2019-03-01
Est. completion2030-03-01
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT03882580

Summary

Several Drugs used in routine care in oncology induce rare but often severe or fatal cardiovascular or metabolic side effects. This study will investigate, evaluate, report and treat the cardiovascular side effects of anticancer drugs, through a specific cardiovascular routine checkup and follow-up taking place in several Cardio-oncology programs throughout France. The different including centers will be: Assistance Publique - Hôpitaux de Paris (APHP.6: Pitié-Salpétrière, Saint Antoine and Tenon's hospitals, Paris, France).

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Suffering a cancer
* Evaluated within a cardio-oncology program

Exclusion Criteria:

* None

Conditions10

CancerCardiac ComplicationCardiac DisorderCardiac InsufficiencyCardiovascular ComplicationCardiovascular InsufficiencyHeart DiseaseMetabolic DisorderOncologic ComplicationsVascular Disorder

Interventions1

Anti-Cancer Agents

Browse More Trials

Cancer trialsHeart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.